The results of the study, published by NEJM, showed that COVID-19 patients who did not need mechanical ventilation to begin with had a higher likelihood of needing ventilation or dying when they were put on hydroxychloroquine
Antibody drug could prevent COVID-19 hospitalizations, says Eli Lilly based on partial trial results
The drug may keep mild to moderately ill COVID-19 patients from hospitalized, a goal no current COVID-19 drug has managed to do.
Zenara Pharma gets DCGI approval to sell Favipiravir tablet Favizen to treat mild to moderate COVID-19 infections
The company is in talks with various institutions to make the tablets available at discounted or no cost to underprivileged patients.
These include medicines ranging from antibiotics and steroids to diarrhea pills to 79 countries on the World Bank’s list of low- and lower-middle-income nations.
Favipiravir is a broad-spectrum antiviral drug that was originally made to treat the flu in Japan.
Coronavirus Outbreak: US becomes world's first country to record over 2,000 COVID-19 deaths in single day
The COVID-19 positive cases in the United States are now more than the other top countries taken together: Spain (158,000), Italy (147,000), Germany (122,000) and France (112,000).
Donald Trump says 10 COVID-19 drugs under clinical trial in US as part of govt's 'unprecedented' effort to find solution to coronavirus outbreak
Responding to questions, Vice President Mike Pence said the US was having four separate clinical trials on the anti-malarial drug hydroxychloroquine.
COVID-19 India Roundup: Cases cross 5,000, hotspots in UP and East Delhi sealed, lockdown likely to be lifted in phases
According to the Ministry of Health and Family Welfare (MoHFW), 5,194 cases have been confirmed so far, 773 of which were confirmed in the last 24 hours.
In approving hydroxychloroquine, ICMR emphasized that it was only for health workers and caregivers treating sick family members.